Literature DB >> 1309922

Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages.

C W Olsen1, W V Corapi, C K Ngichabe, J D Baines, F W Scott.   

Abstract

Antibody-dependent enhancement of virus infection is a process whereby virus-antibody complexes initiate infection of cells via Fc receptor-mediated endocytosis. We sought to investigate antibody-dependent enhancement of feline infectious peritonitis virus infection of primary feline peritoneal macrophages in vitro. Enhancement of infection was assessed, after indirect immunofluorescent-antibody labelling of infected cells, by determining the ratio between the number of cells infected in the presence and absence of virus-specific antibody. Infection enhancement was initially demonstrated by using heat-inactivated, virus-specific feline antiserum. Functional compatibility between murine immunoglobulin molecules and feline Fc receptors was demonstrated by using murine anti-sheep erythrocyte serum and an antibody-coated sheep erythrocyte phagocytosis assay. Thirty-seven murine monoclonal antibodies specific for the nucleocapsid, membrane, or spike proteins of feline infectious peritonitis virus or transmissible gastroenteritis virus were assayed for their ability to enhance the infectivity of feline infectious peritonitis virus. Infection enhancement was mediated by a subset of spike protein-specific monoclonal antibodies. A distinct correlation was seen between the ability of a monoclonal antibody to cause virus neutralization in a routine cell culture neutralization assay and its ability to mediate infection enhancement of macrophages. Infection enhancement was shown to be Fc receptor mediated by blockade of antibody-Fc receptor interaction using staphylococcal protein A. Our results are consistent with the hypothesis that antibody-dependent enhancement of feline infectious peritonitis virus infectivity is mediated by antibody directed against specific sites on the spike protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309922      PMCID: PMC240797     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Antibody-mediated enhancement of respiratory syncytial virus infection in two monocyte/macrophage cell lines.

Authors:  L R Krilov; L J Anderson; L Marcoux; V R Bonagura; J F Wedgwood
Journal:  J Infect Dis       Date:  1989-11       Impact factor: 5.226

2.  Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1.

Authors:  H Ochiai; M Kurokawa; K Hayashi; S Niwayama
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

3.  Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals.

Authors:  J Homsy; M Meyer; J A Levy
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

4.  Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly.

Authors:  H Vennema; L Heijnen; A Zijderveld; M C Horzinek; W J Spaan
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

5.  Antibody-mediated infection of macrophages and macrophage-like cell lines with 17D-yellow fever virus.

Authors:  J J Schlesinger; M W Brandriss
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

6.  In vitro enhancement of respiratory syncytial virus infection of U937 cells by human sera.

Authors:  H B Gimenez; H M Keir; P Cash
Journal:  J Gen Virol       Date:  1989-01       Impact factor: 3.891

7.  Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages.

Authors:  J S Peiris; S Gordon; J C Unkeless; J S Porterfield
Journal:  Nature       Date:  1981-01-15       Impact factor: 49.962

8.  A new mechanism for the neutralization of enveloped viruses by antiviral antibody.

Authors:  S W Gollins; J S Porterfield
Journal:  Nature       Date:  1986 May 15-21       Impact factor: 49.962

9.  Intrinsic resistance of feline peritoneal macrophages to coronavirus infection correlates with in vivo virulence.

Authors:  C A Stoddart; F W Scott
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

10.  Dengue 4 virus monoclonal antibodies identify epitopes that mediate immune infection enhancement of dengue 2 viruses.

Authors:  D M Morens; C N Venkateshan; S B Halstead
Journal:  J Gen Virol       Date:  1987-01       Impact factor: 3.891

View more
  101 in total

Review 1.  Convalescent plasma: new evidence for an old therapeutic tool?

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Liviana Catalano; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-11-06       Impact factor: 3.443

2.  Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro.

Authors:  A Lissenberg; M M Vrolijk; A L W van Vliet; M A Langereis; J D F de Groot-Mijnes; P J M Rottier; R J de Groot
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Infectivity-neutralizing and hemagglutinin-inhibiting antibody responses to respiratory coronavirus infections of cattle in pathogenesis of shipping fever pneumonia.

Authors:  X Lin; K L O'Reilly; M L Burrell; J Storz
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

4.  Localization of antigenic sites of the S glycoprotein of feline infectious peritonitis virus involved in neutralization and antibody-dependent enhancement.

Authors:  W V Corapi; R J Darteil; J C Audonnet; G E Chappuis
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

5.  Antibody dependent enhancement of frog virus 3 infection.

Authors:  Heather E Eaton; Emily Penny; Craig R Brunetti
Journal:  Virol J       Date:  2010-02-18       Impact factor: 4.099

6.  Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus.

Authors:  W V Corapi; C W Olsen; F W Scott
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

7.  Aleutian mink disease parvovirus infection of mink macrophages and human macrophage cell line U937: demonstration of antibody-dependent enhancement of infection.

Authors:  H Kanno; J B Wolfinbarger; M E Bloom
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

8.  Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.

Authors:  Luis Enjuanes; Marta L Dediego; Enrique Alvarez; Damon Deming; Tim Sheahan; Ralph Baric
Journal:  Virus Res       Date:  2007-04-09       Impact factor: 3.303

9.  The SARS-CoV ferret model in an infection-challenge study.

Authors:  Yong-Kyu Chu; Georgia D Ali; Fuli Jia; Qianjun Li; David Kelvin; Ronald C Couch; Kevin S Harrod; Julie A Hutt; Cheryl Cameron; Susan R Weiss; Colleen B Jonsson
Journal:  Virology       Date:  2008-01-29       Impact factor: 3.616

Review 10.  Dengue hemorrhagic fever in infants: research opportunities ignored.

Authors:  Scott B Halstead; Nguyen Trong Lan; Thein Thein Myint; Than Nu Shwe; Ananda Nisalak; Siripen Kalyanarooj; Suchitra Nimmannitya; Soegeng Soegijanto; David W Vaughn; Timothy P Endy
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.